 |
Neurosov
Last updated: August 02, 2024
Founders: Ana Cristovao, Dina Pereira
Portugal | Funding: $1M (+)
Website: https://Neurosov.com
NeuroSoV is a biotech company focused on the discovery and development of cutting-edge therapies targeted at slowing down neurological disorders. Our first asset targets Parkinson Disease (PD), aiming to deliver the most effective and safe therapeutic solutions to slow-down and treat PD patients, ultimately improving their quality of life.
Website: https://Neurosov.com
NeuroSoV is a biotech company focused on the discovery and development of cutting-edge therapies targeted at slowing down neurological disorders. Our first asset targets Parkinson Disease (PD), aiming to deliver the most effective and safe therapeutic solutions to slow-down and treat PD patients, ultimately improving their quality of life.
